Tenet Healthcare EVP and General Counsel Thomas W. Arnst reported multiple equity transactions. On March 2, 2026, he executed an open-market sale of 24,000 shares of common stock at a weighted average price of about $234.04 per share, leaving him with 8,012 directly held shares.
On February 27, 2026, he received a grant of 7,520 time-based restricted stock units and exercised previously granted restricted stock units from 2023 and 2024, which converted into common stock on a one-for-one basis. Shares totaling 1,496, 4,409, and 14,870 were withheld to cover tax obligations upon vesting at prices based on the closing market price.
Filer submitted a Form 144 reporting a proposed sale of common shares. The filing lists 24,000 shares alongside an amount of $5,616,932.53 and a figure of 86,963,000 tied to the record line, with an 03/02/2026 date and NYSE designation. The securities listed relate to restricted stock vesting on 02/24/2026, 02/27/2026, 02/28/2026, and 03/01/2026
Tenet Healthcare EVP & CFO Sun Park reported the vesting and exercise of 3,800 restricted stock units into 3,800 shares of common stock on February 24, 2026, at a price of $0.00 per share. Following these conversions, Park directly holds 18,379 shares of common stock and 7,602 restricted stock units. The RSUs were granted under the 2019 Stock Incentive Plan on February 24, 2025, vesting in three equal annual installments, with the first one-third vesting on February 24, 2026.
Tenet Healthcare CEO Saumya Sutaria reported an increase in directly owned shares through the vesting of restricted stock units. On February 24, 2026, 18,242 "2025 Restricted Stock Units" were exercised or converted, consistent with their one-for-one conversion into common stock.
The transaction delivered 18,242 shares of common stock at a stated price of $0.00 per share, reflecting settlement of time-based awards rather than an open-market purchase. Following these events, Sutaria directly owned 36,486 restricted stock units and 638,923 shares of common stock, all held as direct ownership.
Footnotes explain that the RSUs were granted under the 2019 Stock Incentive Plan on February 24, 2025, vest in three equal annual installments, and are settled in common stock upon vesting. The reported transaction reflects the first one-third of that grant vesting on February 24, 2026.
Tenet Healthcare executive Paola M. Arbour, EVP and Chief Information Officer, reported the vesting and conversion of equity awards tied to her compensation. On February 24, 2026, 1,267 restricted stock units from her 2025 grant converted into an equal number of shares of Tenet common stock at no exercise price.
The restricted stock units were granted under the 2019 Stock Incentive Plan on February 24, 2025 and vest in three equal annual installments, with this filing covering the first one-third tranche. After these transactions, Arbour directly holds 2,534 restricted stock units and 40,271 shares of common stock, reflecting a routine employee equity vesting rather than an open-market purchase or sale.
Tenet Healthcare executive Lisa Y. Foo reported the vesting and conversion of restricted stock units into common shares. On February 24, 2026, 3,800 of her 2025 Restricted Stock Units converted into 3,800 shares of Tenet Healthcare common stock at no exercise price, reflecting an exercise or conversion of a derivative security.
These restricted stock units were granted under the 2019 Stock Incentive Plan on February 24, 2025 and vest in equal one-third installments on each of the first three anniversaries of the grant date. The first one-third installment vested on February 24, 2026. Following this transaction, she directly holds 53,017 shares of common stock and 7,602 restricted stock units.
TENET HEALTHCARE CORP executive Thomas W. Arnst reported equity-based compensation activity. On February 24, 2026, 3,800 of his 2025 Restricted Stock Units were exercised and converted into 3,800 shares of common stock at a stated price of $0.00 per share.
The units were granted under the 2019 Stock Incentive Plan on February 24, 2025 and vest in three equal annual installments; the first one-third vested on February 24, 2026. After these transactions, he directly holds 7,602 restricted stock units and 41,585 shares of common stock.
Tenet Healthcare’s Principal Accounting Officer, Ramsey R. Scott, reported acquiring shares through the vesting of restricted stock units. On February 24, 2026, 443 restricted stock units converted into 443 shares of common stock at a price of $0.00 per share. Following this derivative exercise, Scott directly owned 9,891 shares of common stock and 888 restricted stock units. The units were granted under the 2019 Stock Incentive Plan, vesting in three equal annual installments, with the first third vesting on February 24, 2026 and settled in common stock.
Tenet Healthcare director Nadja West reported a charitable stock gift. On the reported date, she transferred 1,515 shares of Tenet Healthcare common stock as a bona fide gift to a charitable donor-advised fund, with no sale proceeds received. After this donation, she directly owned 26,965 shares.
Tenet Healthcare EVP and COO Lisa Y. Foo acquired 28,339 shares of common stock through a grant of performance-based restricted stock on February 13, 2026. The award was earned when the Human Resources Committee certified achievement of performance goals for the period from January 1, 2023 to December 31, 2025.
The shares were granted at no cash cost, with a reported price of $0.0000 per share, and increased her directly held common stock to 49,217 shares after the transaction.